| View |
|
DRP-5711-04
|
Capecitabine
|
Procitab 500
|
500 mg
|
Film-Coated Tablet
|
Antineoplastic (Cell Cycle-Specific Agent)
|
Celogen Generics Private Ltd
|
India
|
CLIDP Conversion
|
27 September 2024
|
18 December 2027
|
| View |
|
DRP-5968-13
|
Hydrocortisone (as sodium succinate)
|
Venecort 250
|
250 mg
|
Powder for Injection (IM/IV)
|
Corticosteroid
|
Umedica Laboratories Pvt. Ltd.
|
India
|
CLIDP Conversion
|
24 September 2024
|
29 January 2025
|
| View |
|
DRP-5841-02
|
Epirubicin Hydrochloride
|
Helem-50
|
50 mg
|
Lyophilized Powder for Injection
|
Antineoplastic
|
Celon Laboratories Private Limited
|
India
|
CLIDP Conversion
|
24 September 2024
|
08 August 2029
|
| View |
|
DRP-5518-25
|
Cefixime (as trihydrate)
|
Hypercef
|
100 mg/ 5 mL
|
Powder for Oral Suspension
|
Antibacterial
|
Zim Laboratories Limited
|
India
|
CLIDP Conversion
|
27 September 2024
|
17 September 2029
|
| View |
|
DRP-5367-13
|
Cefuroxime (As Axetil)
|
Kefsyn
|
250 mg/5 mL
|
Powder for Oral Suspension
|
Antibacterial
|
Zim Laboratories Limited
|
India
|
CLIDP Conversion
|
15 September 2024
|
30 June 2029
|
| View |
|
DRP-2237-02
|
Erythromycin (as ethylsuccinate)
|
Ilosone®200
|
200 mg/ 5 mL
|
Powder for Suspension
|
Antibacterial (Macrolide)
|
Lloyd Laboratories, Inc.
|
Philippines
|
CLIDP Conversion
|
29 September 2024
|
05 April 2027
|
| View |
|
DRP-4699-06
|
Betamethasone (as valerate)
|
Retasone
|
1 mg / g (0.1% w/w)
|
Cream
|
Corticosteroid
|
Unijules Life Sciences Limited
|
India
|
CLIDP Conversion
|
24 September 2024
|
13 September 2028
|
| View |
|
DRP-4660-02
|
Methotrexate
|
Omari
|
25 mg/mL (50 mg/2 mL)
|
Solution for Injection (I.M./I.V./Intrathecal)
|
Antineoplastic (Cell Cycle-Specific Agent)
|
Khandelwal Laboratories Pvt. Ltd.
|
India
|
CLIDP Conversion
|
27 September 2024
|
06 September 2028
|
| View |
|
DRP-5486-04
|
Albendazole
|
Avazol
|
400 mg
|
Chewable Tablet
|
Antihelmintic (Benzimidazole Derivative)
|
Scott-Edil Pharmacia Limited
|
India
|
CLIDP Conversion
|
27 September 2024
|
27 August 2029
|
| View |
|
DRP-4804-05
|
Celecoxib
|
None
|
400 mg
|
Capsule
|
Selective COX-2 Inhibitor
|
Stallion Laboratories Pvt. Ltd.
|
India
|
CLIDP Conversion
|
15 September 2024
|
11 October 2028
|
| View |
|
DRP-5279-07
|
Montelukast (as sodium)
|
Montti-S
|
10 mg
|
Tablet
|
Leukotriene Receptor Antagonist
|
Azarias Pharmaceutical Laboratories Inc.
|
Philippines
|
CLIDP Conversion
|
29 September 2024
|
24 April 2029
|
| View |
|
DRP-5486-03
|
Albendazole
|
Heliproz
|
400 mg
|
Chewable Tablet
|
Antihelmintic (Benzimidazole derivative)
|
Scott-Edil Pharmacia Limited
|
India
|
CLIDP Conversion
|
15 September 2024
|
27 August 2029
|
| View |
|
DRP-4490-03
|
Telmisartan + Hydrochlorothiazide
|
Telxibloc Plus
|
80 mg/12.5 mg
|
Tablet
|
Angiotensin II Receptor Blocker/Diuretic
|
Stallion Laboratories Pvt. Ltd.
|
India
|
CLIDP Conversion
|
15 September 2024
|
18 June 2028
|
| View |
|
DRP-3324-01
|
Ciprofloxacin (as Lactate)
|
Kercip 400
|
400 mg/100 mL
|
Solution for IV Infusion
|
Antibacterial (Fluoroquinolone)
|
Techno Drugs Ltd.
|
Bangladesh
|
CLIDP Conversion
|
29 September 2024
|
24 March 2029
|
| View |
|
DRP-3836-11
|
Betahistine Hydrochloride
|
Vertilex
|
16 mg
|
Film-Coated Tablet
|
Anti-Vertigo
|
J.M. Tolmann Laboratories, Inc.
|
Philippines
|
CLIDP Conversion
|
27 September 2024
|
09 December 2025
|
| View |
|
DRP-4298-02
|
Methotrexate
|
Omari Tab
|
2.5 mg
|
Tablet
|
Antineoplastic (Cell cycle-specific agent)
|
Khandelwal Laboratories Pvt. Ltd.
|
India
|
CLIDP Conversion
|
24 September 2024
|
20 March 2028
|
| View |
|
DRP-5493-06
|
Etoricoxib
|
Rilaxia
|
120 mg
|
Film-Coated Tablet
|
Non-Steroidal Anti-Inflammatory Drug/NSAID (Coxib)
|
XL Laboratories Pvt. Ltd.
|
India
|
CLIDP Conversion
|
27 September 2024
|
28 August 2029
|
| View |
|
DRP-15483-02
|
Dapagliflozin (as propanediol monohydrate)
|
Flosazin
|
10 mg
|
Film-Coated Tablet
|
Blood glucose lowering drug [Sodium-glucose co-transporter 2(SGLT2) Inhibitor]
|
Stallion Laboratories Pvt. Ltd.
|
India
|
CLIDP Conversion
|
24 September 2024
|
16 July 2029
|
| View |
|
DRP-15499-01
|
Atorvastatin (as calcium trihydrate)
|
Stadin
|
40 mg
|
Film-Coated Tablet
|
HMG CoA Reductase Inhibitor
|
Lek S.A.
|
Poland
|
CLIDP Conversion
|
29 September 2024
|
29 July 2029
|
| View |
|
DRP-15483-03
|
Dapagliflozin (as propanediol monohydrate)
|
Cardiogly
|
10 mg
|
Film-Coated Tablet
|
Blood glucose lowering drug [Sodium-glucose co-transporter 2(SGLT2) Inhibitor]
|
Stallion Laboratories Pvt. Ltd.
|
India
|
CLIDP Conversion
|
27 September 2024
|
16 July 2029
|